MAPK3 and breast carcinoma: Similarly, in breast cancer, the MCF-7 breast cancer cell secretome (MCF-7-CM) enhanced vascular endothelial cell proliferation while inhibiting lymphatic endothelial cell growth through VEGF-driven activation of ERK1/2 and Akt pathways [39].